Review



cd3-efluor450  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher cd3-efluor450
    Cd3 Efluor450, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/pm39368477-902-60-61
    Average 90 stars, based on 1 article reviews
    cd3-efluor450 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Staining:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Fluorescence:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Control:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Concentration Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Incubation:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Recombinase Polymerase Amplification:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Activation Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Quantitation Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Purification:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Real-time Polymerase Chain Reaction:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Western Blot:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Activity Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Expressing:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Labeling:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Derivative Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Cell Culture:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Immunoprecipitation:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Marker:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Enzyme-linked Immunosorbent Assay:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Bioprocessing:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Luminex:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Software:

    Article Title: Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT
    Article Snippet: Cells were first extracellularly stained with CD3-eFluor450 (eBioscience), CD4 APC-eFluor780 (eBioscience), CD8-V500 (BD Biosciences), CD45RO-PE-Cy7 (BD), CD27-APC (eBioscience), and CD95-PE (BD Biosciences) or with CD19-PerCP (Biolegend), CD27-APC (eBioscience), and IgM-PE (Southern Biotech) monoclonal antibodies.

    Article Title: Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia
    Article Snippet: LY6C-APC (dilution 1:40, BioLegend, Cat.No.

    Article Title: Identifying specific functional roles for senescence across cell types.
    Article Snippet: Cells were then stained with fluorescence-conjugated antibodies for 30 min at 4 C. All antibodies are commercially available: CD45-FITC (eBioscience, Cat# 11-0451-82, 1:200); CD45-APC (eBioscience, Cat# 17-0451-82, 1:200); CD31-FITC (eBioscience, Cat# 11-0311-82, 1:40); CD31-APC (eBioscience, Cat# 17-0311-82, 1:40); F4/80 PE-Cy7 (Biolegend, Cat# 123114, 1:200); F4/80APC (eBioscience, Cat# 17-4801-82, 1:200); CD11b PE-Cy7 (eBioscience, Cat# 25-0112-82, 1:200); CD11b-APC (eBioscience, Cat# 17-0112-81, 1:200) CD3-eFluor450 (Thermo Fisher Scientific, Cat#48-0032-80, 1:200), NK1.1-APC (Thermo Fisher Scientific, Cat#17-5941-82, 1:200).

    Article Title: NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8 + T cell Effector Function
    Article Snippet: Samples were then stained for viability with LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit (Invitrogen), blocked with Fc-block (ThermoFisher), permeabilized with ice-cold 90% methanol, and stained for surface markers CD3-eFluor450 (UCHT1, eBioscience), CD4-FITC (RPA-T4, Biolegend), CD8-BV711 (SK1, Biolegend) as well as intracellular molecules Phospho-S6 (Ser235, Ser236)-PE (cupk43k, ThermoFisher) and Phospho-AKT1 (Ser473)-APC (SDRNR, ThermoFisher).

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEAL×5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEAL×b12-FEAR, bsIgG1-b12-FEAL×5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).

    Article Title: Antibodies
    Article Snippet: T cells were derived from human donor buffy coats (Sanquin, Amsterdam, The Netherlands) and isolated using the RosetteSep human T cell enrichment cocktail (Stemcell Technologies, France, cat. no. 15061) according to manufacturer's instructions.

    Article Title: Antibodies
    Article Snippet: Serial dilutions of bsIgG1-huCD3-H101G-FEALx5T4-207-FEAR or control antibodies (bsIgG1-huCD3-H101G-FEALxb12-FEAR, bsIgG1-b12-FEALx5T4-207-FEAR) were added (final concentration ranging from 5000 to 0.0128 ng/mL; 5-fold dilutions) and plates were incubated at 37° C. for 72 h. Next, 110 μL supernatants containing T cells were transferred to round-bottom 96-well culture plates (CellStar, cat. no. 650180) and centrifuged (300×g) at 4° C. for 3 min. T cells were stained for T-cell markers by incubation with CD3-eFluor450 (1:200; eBioscience, clone OKT3), CD4-APC-eFluor780 (1:50; eBioscience, clone OKT4), CD8-AF700 (1:100; Biolegend, clone RPA-T8) and T-cell activation markers CD69-APC (1:50; BD Biosciences, clone AB2439), CD25-PE-Cy7 (1:50; eBioscience, clone BC96) and CD279/PD1-BV605 (1:50; Biolegend, clone EH12.2H7) diluted in 50 μL PBS/0.1% BSA/0.02% azide (staining buffer).



    Similar Products

    90
    Thermo Fisher cd3-efluor450
    Cd3 Efluor450, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/pm39368477-902-60-61
    Average 90 stars, based on 1 article reviews
    cd3-efluor450 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cd3 efluor450 clone ucht1
    Anti Cd3 Efluor450 Clone Ucht1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/anti+cd3e/med_rxiv__2025__06__05__25328514-209-17-21
    Average 90 stars, based on 1 article reviews
    anti-cd3 efluor450 clone ucht1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cd3-efluor450 clone okt3
    Anti Cd3 Efluor450 Clone Okt3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/anti+cd3/us12227572-528-7-12
    Average 90 stars, based on 1 article reviews
    anti-cd3-efluor450 clone okt3 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher efluor450-cd3 antibody
    Efluor450 Cd3 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/cell+proliferation+dye+efluor+450/pm39031098-467-17-24
    Average 90 stars, based on 1 article reviews
    efluor450-cd3 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd3-efluor450 48–0037-42 antibody
    Cd3 Efluor450 48–0037 42 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/cell+proliferation+dye+efluor+450/pmc11411782-168-6-8
    Average 90 stars, based on 1 article reviews
    cd3-efluor450 48–0037-42 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd3-efluor450 antibody
    Cd3 Efluor450 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd3-efluor450/cell+proliferation+dye+efluor+670/pm39068754-98-2-28
    Average 90 stars, based on 1 article reviews
    cd3-efluor450 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results